JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 49 filers reported holding JANUX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,877,323 | -2.7% | 446,266 | 0.0% | 1.58% | +36.4% |
| Q3 2022 | $6,042,000 | +10.9% | 446,266 | 0.0% | 1.16% | -14.1% |
| Q2 2022 | $5,449,000 | -14.8% | 446,266 | 0.0% | 1.35% | -3.6% |
| Q1 2022 | $6,399,000 | -27.3% | 446,266 | 0.0% | 1.40% | -15.4% |
| Q4 2021 | $8,805,000 | -8.8% | 446,266 | 0.0% | 1.65% | -15.7% |
| Q3 2021 | $9,653,000 | -13.3% | 446,266 | 0.0% | 1.96% | -30.0% |
| Q2 2021 | $11,134,000 | – | 446,266 | – | 2.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $117,401,000 | 2.50% |
| 5AM Venture Management, LLC | 446,266 | $6,042,000 | 1.16% |
| Samsara BioCapital, LLC | 360,414 | $4,880,000 | 1.14% |
| BVF INC/IL | 1,470,334 | $19,908,000 | 0.82% |
| Orbimed Advisors | 2,836,386 | $38,405,000 | 0.71% |
| EcoR1 Capital, LLC | 1,421,319 | $19,245,000 | 0.57% |
| Woodline Partners LP | 400,181 | $5,418,000 | 0.08% |
| Parkwood LLC | 33,352 | $452,000 | 0.07% |
| JANUS HENDERSON GROUP PLC | 3,920,088 | $26,572,546 | 0.02% |
| Cerity Partners LLC | 105,933 | $1,434,000 | 0.02% |